PTPRC and neoplasm: Indeed, C57BL/6 mice bearing E0771 tumors in the mammary fat pad and treated with ONC201 showed a significantly increased percentage of NK cells (NK1.1+, CD3-, CD19-) within the tumor infiltrating lymphocytes (CD45+) (Supplementary Figure 5A).